488 related articles for article (PubMed ID: 15468596)
21. Use of herpes simplex virus type 1-based amplicon vector for delivery of small interfering RNA.
Sabbioni S; Callegari E; Manservigi M; Argnani R; Corallini A; Negrini M; Manservigi R
Gene Ther; 2007 Mar; 14(5):459-64. PubMed ID: 17051250
[TBL] [Abstract][Full Text] [Related]
22. Vectors for RNA interference.
Wadhwa R; Kaul SC; Miyagishi M; Taira K
Curr Opin Mol Ther; 2004 Aug; 6(4):367-72. PubMed ID: 15468595
[TBL] [Abstract][Full Text] [Related]
23. Lentiviral vector engineering for anti-HIV RNAi gene therapy.
ter Brake O; Westerink JT; Berkhout B
Methods Mol Biol; 2010; 614():201-13. PubMed ID: 20225046
[TBL] [Abstract][Full Text] [Related]
24. Novel methods for expressing RNA interference in human cells.
Sano M; Kato Y; Akashi H; Miyagishi M; Taira K
Methods Enzymol; 2005; 392():97-112. PubMed ID: 15644177
[TBL] [Abstract][Full Text] [Related]
25. RNAi in combination with a ribozyme and TAR decoy for treatment of HIV infection in hematopoietic cell gene therapy.
Li M; Li H; Rossi JJ
Ann N Y Acad Sci; 2006 Oct; 1082():172-9. PubMed ID: 17145937
[TBL] [Abstract][Full Text] [Related]
26. Therapeutic potential of RNA interference against cancer.
Takeshita F; Ochiya T
Cancer Sci; 2006 Aug; 97(8):689-96. PubMed ID: 16863503
[TBL] [Abstract][Full Text] [Related]
27. Lentiviral vectors that carry anti-HIV shRNAs: problems and solutions.
ter Brake O; Berkhout B
J Gene Med; 2007 Sep; 9(9):743-50. PubMed ID: 17628029
[TBL] [Abstract][Full Text] [Related]
28. Long-term inhibition of HIV-1 infection in primary hematopoietic cells by lentiviral vector delivery of a triple combination of anti-HIV shRNA, anti-CCR5 ribozyme, and a nucleolar-localizing TAR decoy.
Li MJ; Kim J; Li S; Zaia J; Yee JK; Anderson J; Akkina R; Rossi JJ
Mol Ther; 2005 Nov; 12(5):900-9. PubMed ID: 16115802
[TBL] [Abstract][Full Text] [Related]
29. A tightly regulated and reversibly inducible siRNA expression system for conditional RNAi-mediated gene silencing in mammalian cells.
Wu RH; Cheng TL; Lo SR; Hsu HC; Hung CF; Teng CF; Wu MP; Tsai WH; Chang WT
J Gene Med; 2007 Jul; 9(7):620-34. PubMed ID: 17486668
[TBL] [Abstract][Full Text] [Related]
30. RNA interference in mice.
Kühn R; Streif S; Wurst W
Handb Exp Pharmacol; 2007; (178):149-76. PubMed ID: 17203655
[TBL] [Abstract][Full Text] [Related]
31. Effective gene suppression using small interfering RNA in hard-to-transfect human T cells.
Yin J; Ma Z; Selliah N; Shivers DK; Cron RQ; Finkel TH
J Immunol Methods; 2006 May; 312(1-2):1-11. PubMed ID: 16603179
[TBL] [Abstract][Full Text] [Related]
32. Development and characterization of a triple combination gene therapy vector inhibiting HIV-1 multiplication.
Asparuhova MB; Barde I; Trono D; Schranz K; Schümperli D
J Gene Med; 2008 Oct; 10(10):1059-70. PubMed ID: 18642399
[TBL] [Abstract][Full Text] [Related]
33. siRNAs, ribozymes and RNA decoys in modeling stem cell-based gene therapy for HIV/AIDS.
Akkina R; Banerjea A; Bai J; Anderson J; Li MJ; Rossi J
Anticancer Res; 2003; 23(3A):1997-2005. PubMed ID: 12894572
[TBL] [Abstract][Full Text] [Related]
34. RNA interference for the identification of disease-associated genes.
Nencioni A; Sandy P; Dillon C; Kissler S; Blume-Jensen P; Van Parijs L
Curr Opin Mol Ther; 2004 Apr; 6(2):136-40. PubMed ID: 15195924
[TBL] [Abstract][Full Text] [Related]
35. RNA interference and HIV-1 infection.
Kanzaki LI; Ornelas SS; Argañaraz ER
Rev Med Virol; 2008; 18(1):5-18. PubMed ID: 17764099
[TBL] [Abstract][Full Text] [Related]
36. Optimization of an siRNA-expression system with an improved hairpin and its significant suppressive effects in mammalian cells.
Miyagishi M; Sumimoto H; Miyoshi H; Kawakami Y; Taira K
J Gene Med; 2004 Jul; 6(7):715-23. PubMed ID: 15241778
[TBL] [Abstract][Full Text] [Related]
37. A conditionally replicating HIV-based vector that stably expresses an antiviral shRNA against HIV-1 replication.
Westerhout EM; Vink M; Haasnoot PC; Das AT; Berkhout B
Mol Ther; 2006 Aug; 14(2):268-75. PubMed ID: 16697708
[TBL] [Abstract][Full Text] [Related]
38. Intracellular-diced dsRNA has enhanced efficacy for silencing HCV RNA and overcomes variation in the viral genotype.
Watanabe T; Sudoh M; Miyagishi M; Akashi H; Arai M; Inoue K; Taira K; Yoshiba M; Kohara M
Gene Ther; 2006 Jun; 13(11):883-92. PubMed ID: 16496015
[TBL] [Abstract][Full Text] [Related]
39. RNA interference and its current application in mammals.
Shen WG
Chin Med J (Engl); 2004 Jul; 117(7):1084-91. PubMed ID: 15265387
[TBL] [Abstract][Full Text] [Related]
40. Evidence that HIV-1 encodes an siRNA and a suppressor of RNA silencing.
Bennasser Y; Le SY; Benkirane M; Jeang KT
Immunity; 2005 May; 22(5):607-19. PubMed ID: 15894278
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
